Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global Market · Equity
$37.545
+$0.615 · +1.67%
· Aug 21, 4:00 PM ET
$37.545
Previous close+$0.615 · +1.67%
· Aug 21, 4:00 PM ET
$37.4602
+$0.5302 · +1.44%
Regular session · ET · Market data may be delayed.
The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic valuation realization and scientific discovery.
Fund assets
17.8M USD
Expense ratio
0.85%
NAV
$36.48
Average volume
1.94K
Volume
3.8K
Day range
$37.24 – $37.62
52-week range
$28.322 – $37.90
Previous close
$36.93
Price change
1 day
+1.67%
1 month
+5.79%
3 months
+11.38%
Year to date
+13.09%
1 year
+32.34%
3 years
+24.40%
5 years
+20.68%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Fund income
Dec 23, 2025
Annual
Dec 23, 2025
Dec 24, 2025
$0.4088
Dec 24, 2024
Annual
Dec 24, 2024
Dec 26, 2024
$0.5071
Dec 27, 2023
Annual
Dec 28, 2023
Dec 29, 2023
$1.6423
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
